発泡性製品の世界市場：2023-2030年

世界の発泡性製品市場は、予測期間中（2023-2030年）にCAGR 7.51%で成長すると予測されています。発泡性製品は、液体に素早く溶けるように特別に設計されており、有効成分の体内吸収を促進します。発泡プロセスは、製品をより小さな粒子に分解するのを助ける気泡性溶液を作り出し、それによって溶解性と吸収率を向上させる。発泡性製品のこのユニークな特性は、バイオアベイラビリティの向上、健康・ウェルネス動向の高まりへの対応、消費者へのカスタマイズ可能な選択肢と幅広い選択肢の提供など、市場においていくつかの重要な利点を提供します。

例えば、2021年10月、ベネオが発売したフィラー結合剤GalenIQ 721があります。GalenIQ 721は、発泡性錠剤や粉末の風味と安定性を高める充填結合剤として機能します。この賦形剤は、非吸湿性、水溶性、即時圧縮性であり、発泡用途に非常に適しています。そのユニークな特性は、発泡性製品の製造において、安定した高品質の含有量と生産効率を保証します。

効率的で即効性のあるヘルスケアやウェルネス・ソリューションへの需要が高まる中、発泡性製品は消費者に好まれる選択肢となりつつあります。これらの製品が提供する投与のしやすさと吸収率の向上が、人気の原動力となっています。メーカー各社が革新的な賦形剤や製剤を開発・導入し続けていることから、世界の発泡性製品市場は今後数年間、持続的な成長と広範な普及が見込まれています。

セグメント別展望

発泡性錠剤のサブセグメントが世界の発泡性製品市場でかなりのシェアを占めると予測される

製品形態のうち、発泡性錠剤のサブセグメントが世界の発泡性製品市場でかなりのシェアを占めると予想されます。発泡性錠剤は、通常の錠剤やカプセルを飲み込むのが困難な人々にとって有用なソリューションです。水に素早く溶け、心地よい発泡性の口当たりが得られます。栄養補助食品、医薬品、パーソナルケアアイテム、その他の分野で使用するための幅広い製剤で利用可能なため、発泡性錠剤はより大きな市場の可能性と高い顧客需要を持っています。例えば、2023年1月、英国を拠点とする成長中の製薬会社Kelso Pharmaは、初の製品として、英国の処方薬市場向けにAcepiro（アセチルシステイン）600mg発泡性錠剤を発売すると発表しました。

地域別展望

世界の発泡性錠剤市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋地域（インド、中国、日本、韓国、その他アジア地域）、世界のその他の地域（中東とアフリカ、南米）を含む地域別にさらに細分化されています。なかでもアジア太平洋地域は、ファイザー、GSK plc、ノバルティスAG、ペリゴ・カンパニーplc、レキットベンキーザー・グループPLCなど、市場ソリューションベンダーが集中していることから、世界全体で大きなシェアを占めると予想されます。

北米地域は世界の発泡性製品市場において著しいCAGRで成長する見込み

すべての地域の中で、北米地域は予測期間中にかなりのCAGRで成長すると予想されています。発泡性製品の市場拡大は、北米消費者の健康意識の高まりに起因しています。これらの製品は、健康状態を改善し、免疫サポート、水分補給、活力などのメリットをもたらす可能性があるとして求められています。消費者は予防医療に対する意識の高まりから、総合的なウェルネスをサポートする製品を求めており、Apparent Sent Formulationsはこの要望に応えています。発泡性製品の主要企業は北米市場に進出しており、その恩恵を受けています。新しい発泡性製品ラインは、顧客の需要の環境に対応するために製薬企業によって積極的に導入されています。

その明確な品質と利点のために、発泡性製品は、北米の消費者の間でますます人気が高まっています。これらの製品は、水に溶かすと泡が出る正式な文字で、フィジーのような体験ができます。医薬品、パーソナルケア、ヘルスケア分野で頻繁に使用されています。発泡性の錠剤、粉末、顆粒は広く入手可能で、消費者に便利で使いやすい選択肢を提供しています。

目次

第1章 レポート概要

• 業界の現状分析と成長ポテンシャルの展望
• 調査方法とツール
• 市場内訳
  • セグメント別
  • 地域別

第2章 市場概要と洞察

• 調査範囲
• アナリストの洞察と現在の市場動向
  • 主な調査結果
  • 推奨事項
  • 結論

第3章 競合情勢

• 主要企業分析
• GSK plc
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Novartis AG
  • 会社概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Pfizer Inc.
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• 主要戦略分析

第4章 市場セグメンテーション

• エフェルヴェッセント製品の世界市場：製品形態別
  • 錠剤
  • 適応症
  • 顆粒剤
• 効能別にみた去痰剤の世界市場
  • 利尿剤
  • 疼痛管理
  • 胃疾患
  • 呼吸器疾患
• 整腸剤の世界市場：流通チャネル別
  • 病院薬局
  • オンライン薬局
  • 小売薬局

第5章 地域分析

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • イタリア
  • スペイン
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 世界のその他の地域

第6章 企業プロファイル

• Alpex
• Amerilab Technologies Inc.
• Bliss GVS Pharma Ltd.
• Bristol-Myers Squibb Co.
• GlaxoSmithKline PLC
• Herbalife Nutrition Ltd.
• Hermes Arzneimittel
• JW Nutritional Inc.
• Nuun and Company Inc.
• Paragon Laboratories
• Pyramid Pharmaceuticals
• S.G Biopharm pvt. Ltd
• Swisse Wellness pty Ltd
• Vitabiotics Ltd
• Vovantis Laboratories Pvt. Ltd.

LIST OF TABLES

• 1. GLOBAL EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY PRODUCT FORM, 2022-2030 ($ MILLION)
• 2. GLOBAL EFFERVESCENT PRODUCTS AS TABLETS MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
• 3. GLOBAL EFFERVESCENT PRODUCTS AS POWDER MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
• 4. GLOBAL EFFERVESCENT PRODUCTS AS GRANULES MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
• 5. GLOBAL EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022-2030 ($ MILLION)
• 6. GLOBAL EFFERVESCENT PRODUCTS FOR DIURETIC MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 7. GLOBAL EFFERVESCENT PRODUCTS FOR PAIN MANAGEMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 8. GLOBAL EFFERVESCENT PRODUCTS FOR GASTRIC DISORDER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 9. GLOBAL EFFERVESCENT PRODUCTS FOR RESPIRATORY DISORDER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 10. GLOBAL EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
• 11. GLOBAL EFFERVESCENT PRODUCTS BY HOSPITAL PHARMACY MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
• 12. GLOBAL EFFERVESCENT PRODUCTS BY ONLINE PHARMACY MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
• 13. GLOBAL EFFERVESCENT PRODUCTS BY RETAIL PHARMACY MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
• 14. GLOBAL EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 15. NORTH AMERICAN EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 16. NORTH AMERICAN EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY PRODUCT FORM, 2022-2030 ($ MILLION)
• 17. NORTH AMERICAN EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022-2030 ($ MILLION)
• 18. NORTH AMERICAN EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY DISTIBUTION CHANNEL, 2022-2030 ($ MILLION)
• 19. EUROPEAN EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 20. EUROPEAN EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY PRODUCT FORM, 2022-2030 ($ MILLION)
• 21. EUROPEAN EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022-2030 ($ MILLION)
• 22. EUROPEAN EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
• 23. ASIA- PACIFIC EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 24. ASIA- PACIFIC EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY PRODUCT FORM, 2022-2030 ($ MILLION)
• 25. ASIA- PACIFIC EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022-2030 ($ MILLION)
• 26. ASIA- PACIFIC EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
• 27. REST OF THE WORLD EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 28. REST OF THE WORLD EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY PRODUCT FORM, 2022-2030 ($ MILLION)
• 29. REST OF THE WORLD EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022-2030 ($ MILLION)
• 30. REST OF THE WORLD EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)

LIST OF FIGURES

• 1. GLOBAL EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY PRODUCT FORM, 2022 VS 2030 (%)
• 2. GLOBAL EFFERVESCENT PRODUCTS AS TABLETS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
• 3. GLOBAL EFFERVESCENT PRODUCTS AS POWDER MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
• 4. GLOBAL EFFERVESCENT PRODUCTS AS GRANULES MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
• 5. GLOBAL EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022 VS 2030 (%)
• 6. GLOBAL EFFERVESCENT PRODUCTS FOR DIURETIC MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
• 7. GLOBAL EFFERVESCENT PRODUCTS FOR PAIN MANAGEMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
• 8. GLOBAL EFFERVESCENT PRODUCTS FOR GASTRIC DISORDER MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
• 9. GLOBAL EFFERVESCENT PRODUCTS FOR RESPIRATORY DISORDER MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
• 10. GLOBAL EFFERVESCENT PRODUCTS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
• 11. GLOBAL EFFERVESCENT PRODUCTS BY HOSPITAL PHARMACY MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
• 12. GLOBAL EFFERVESCENT PRODUCTS BY ONLINE PHARMACY MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
• 13. GLOBAL EFFERVESCENT PRODUCTS BY RETAIL PHARMACY MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
• 14. GLOBAL EFFERVESCENT PRODUCTS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 15. US EFFERVESCENT PRODUCTS MARKET SIZE, 2022-2030 ($ MILLION)
• 16. CANADA EFFERVESCENT PRODUCTS MARKET SIZE, 2022-2030 ($ MILLION)
• 17. UK EFFERVESCENT PRODUCTS MARKET SIZE, 2022-2030 ($ MILLION)
• 18. FRANCE EFFERVESCENT PRODUCTS MARKET SIZE, 2022-2030 ($ MILLION)
• 19. GERMANY EFFERVESCENT PRODUCTS MARKET SIZE, 2022-2030 ($ MILLION)
• 20. ITALY EFFERVESCENT PRODUCTS MARKET SIZE, 2022-2030 ($ MILLION)
• 21. SPAIN EFFERVESCENT PRODUCTS MARKET SIZE, 2022-2030 ($ MILLION)
• 22. REST OF EUROPE EFFERVESCENT PRODUCTS MARKET SIZE, 2022-2030 ($ MILLION)
• 23. INDIA EFFERVESCENT PRODUCTS MARKET SIZE, 2022-2030 ($ MILLION)
• 24. CHINA EFFERVESCENT PRODUCTS MARKET SIZE, 2022-2030 ($ MILLION)
• 25. JAPAN EFFERVESCENT PRODUCTS MARKET SIZE, 2022-2030 ($ MILLION)
• 26. SOUTH KOREA EFFERVESCENT PRODUCTS MARKET SIZE, 2022-2030 ($ MILLION)
• 27. REST OF ASIA-PACIFIC EFFERVESCENT PRODUCTS MARKET SIZE, 2022-2030 ($ MILLION)
• 28. REST OF THE WORLD EFFERVESCENT PRODUCTS MARKET SIZE, 2022-2030 ($ MILLION)

Title: Global Effervescent Products Market Size, Share & Trends Analysis Report by Product Form (Effervescent Tablets, Effervescent Powders, Effervescent Granules), by Indication (Diuretics, Pain Management, Gastric Disorders Respiratory Diseases), and by Distribution channel (Hospital Pharmacy, Online Pharmacy. Retail Pharmacy),Forecast Period (2023-2030).

The global effervescent products market is anticipated to grow at a CAGR of 7.51% during the forecast period (2023-2030). Effervescent products are specifically designed to dissolve quickly in fluids, facilitating the rapid absorption of their active ingredient by the body. The effervescence process creates a bubbly solution that aids in breaking down the product into smaller particles, thereby improving its solubility and absorption rate. This unique characteristic of effervescent products offers several key advantages in the market, including enhanced bioavailability, aligning with the rising health and wellness trends, and providing customizable options and a wide variety of choices for consumers.

For Instance, in October 2021, GalenIQ 721, a filler-binder that launched by Beneo. GalenIQ 721 serves as a filler-binder that enhances the flavor and consistency of effervescent tablets and powders. This excipient is non-hygroscopic, water-soluble, and immediately compressible, making it highly suitable for effervescent applications. Its unique properties ensure consistent high-quality content and production efficiency in the manufacturing of effervescent products.

With the increasing demand for efficient and fast-acting healthcare and wellness solutions, effervescent products are becoming a preferred choice for consumers. The ease of administration and improved absorption rate offered by these products are driving factors behind their popularity. As manufacturers continue to develop and introduce innovative excipients and formulations, the global effervescent product market is expected to witness sustained growth and widespread adoption in the coming years.

Segmental Outlook

The global effervescent products market is segmented on by product forms, by Indication, and by distribution channel. Based on the product forms, the market is sub-segmented into effervescent tablets, effervescent powders, effervescent granules. Based on the Indication, the market is sub-segmented into diuretics, pain management, gastric disorders respiratory diseases. Further, on the basis of distribution channel, the market is sub-segmented into hospital pharmacy, online pharmacy. retail pharmacy. Among the distribution channel, the online pharmacy sub-segment is anticipated to hold a considerable share of the market owing due to more emphasis is being placed on developing unique and appealing solutions. This development has caused online pharmacies, which provide consumers with accessible and convenient healthcare services, to soar in popularity.

The Effervescent Tablets Sub-Segment is Anticipated to Hold a Considerable Share of the Global Effervescent Products Market

Among the product form, the effervescent tablets sub-segment is expected to hold a considerable share of the global effervescent product market. Effervescent Tablets are a useful solution for people who have trouble swallowing regular pills or capsules. Due to it dissolve quickly in water and produce a pleasant and fizzy mouthfeel. Due to their availability in a wide range of formulations for use in nutritional supplements, medicines, personal care items, and other areas, effervescent tablets have a larger market potential and higher customer demand. For Instance, in January 2023, the growing UK-based pharmaceutical company Kelso Pharma has announced the launching of Acepiro (Acetylcysteine) 600mg effervescent tablets for the UK prescription medicine market as its maiden product launch.

Regional Outlook

The global effervescent tablets market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the high concentration of the market solution vendors including Pfizer Inc., GSK plc, Novartis AG, Perrigo Company plc, Reckitt Benckiser Group PLC and others.

The North America Region is Expected to Grow at a Significant CAGR in the Global Effervescent Products Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. The market expansion for effervescent products is being attributed to the increase in health consciousness among North American consumers. These products are sought after for their potential to improve wellness and provide benefits including immune support, hydration, and vitality. Consumers are looking for products to support their overall welding due to rising awareness of preventive healthcare, and Apparent Sent Formulations are meeting this desire. Key players in the effervescent product companies are present in the North American market, which benefits from their presence. New effervescent product lines are being aggressively introduced by pharmaceutical businesses to cater to the environment of customer demands.

Due to their distinct qualities and advantages, effervescent products are becoming more and more popular among consumers in North America. These products are formal letters that release bubbles when dissolved in water, creating the Fijian experience. They are frequently used in the pharmaceutical, personal care, and healthcare sectors. Effervescent tablets, powders, and granules are widely accessible and provide consumers with a convenient and simple to use option.

Market Players Outlook

The major companies serving the effervescent products market include: Pfizer Inc., GSK plc, Novartis AG, Perrigo Company plc, Reckitt Benckiser Group PLC, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For Instance, in February 2022, the Procter and Gamble company (P&G) launched boost vitamin, an Australian effervescent supplementary brand in measure retailers in Singapore. The product is available in seven SKUs and is sold in the nation's top pharmacies, supermarkets, and online retailers.

The Report Covers:

• Market value data analysis of 2022 and forecast to 2030.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global effervescent products market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
• 3.2. GSK plc
  • 3.2.1. Overview
  • 3.2.2. Financial Analysis
  • 3.2.3. SWOT Analysis
  • 3.2.4. Recent Developments
• 3.3. Novartis AG
  • 3.3.1. Overview
  • 3.3.2. Financial Analysis
  • 3.3.3. SWOT Analysis
  • 3.3.4. Recent Developments
• 3.4. Pfizer Inc.
  • 3.4.1. Overview
  • 3.4.2. Financial Analysis
  • 3.4.3. SWOT Analysis
  • 3.4.4. Recent Developments
• 3.5. Key Strategy Analysis

4. Market Segmentation

• 4.1. Global Effervescent Products Market by Product Forms
  • 4.1.1. Tablets
  • 4.1.2. Indication
  • 4.1.3. Granules
• 4.2. Global Effervescent Products Market by Indication
  • 4.2.1. Diuretics
  • 4.2.2. Pain Management
  • 4.2.3. Gastric Disorders
  • 4.2.4. Respiratory Diseases
• 4.3. Global Effervescent Products Market by Distribution Channel
  • 4.3.1. Hospital Pharmacy
  • 4.3.2. Online Pharmacy
  • 4.3.3. Retail Pharmacy

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World

6. Company Profiles

• 6.1. Alpex
• 6.2. Amerilab Technologies Inc.
• 6.3. Bliss GVS Pharma Ltd.
• 6.4. Bristol-Myers Squibb Co.
• 6.5. GlaxoSmithKline PLC
• 6.6. Herbalife Nutrition Ltd.
• 6.7. Hermes Arzneimittel
• 6.8. JW Nutritional Inc.
• 6.9. Nuun and Company Inc.
• 6.10. Paragon Laboratories
• 6.11. Pyramid Pharmaceuticals
• 6.12. S.G Biopharm pvt. Ltd
• 6.13. Swisse Wellness pty Ltd
• 6.14. Vitabiotics Ltd
• 6.15. Vovantis Laboratories Pvt. Ltd.